Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7260)
All Articles published online
|
Jan 7, 2008 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kallwitz ER, McLachlan A, Cotler SJ. Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease. World J Gastroenterol 2008; 14(1): 22-28 [PMID: 18176957 DOI: 10.3748/wjg.14.22] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i1/22.htm |
| Number | Citing Articles |
| 1 |
Yan Zhang, Yan Cui, Xiao-Li Wang, Xiang Shang, Zhi-Gang Qi, Jie Xue, Xi Zhao, Min Deng, Mei-Lin Xie. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats. Cytokine 2015; 75(1): 127 doi: 10.1016/j.cyto.2015.05.031
|
| 2 |
B Gross, N Hennuyer, E Bouchaert, C Rommens, D Grillot, H Mezdour, B Staels. Generation and characterization of a humanized PPARδ mouse model. British Journal of Pharmacology 2011; 164(1): 192 doi: 10.1111/j.1476-5381.2011.01359.x
|
| 3 |
Yaoyao Jia, Jin-Young Kim, Hee-jin Jun, Sun-Joong Kim, Ji-Hae Lee, Minh Hien Hoang, Hyun Sook Kim, Hyo Ihl Chang, Kwang-Yeon Hwang, Soo-Jong Um, Sung-Joon Lee. Cyanidin is an agonistic ligand for peroxisome proliferator-activated receptor-alpha reducing hepatic lipid. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2013; 1831(4): 698 doi: 10.1016/j.bbalip.2012.11.012
|
| 4 |
YUNLIANG WANG, JIAN LI, LI ZHUGE, DONGMEI SU, MEIJUAN YANG, SHIYING TAO, JUNXIANG LI. Comparison between the efficacies of curcumin and puerarin in C57BL/6 mice with steatohepatitis induced by a methionine- and choline-deficient diet. Experimental and Therapeutic Medicine 2014; 7(3): 663 doi: 10.3892/etm.2013.1461
|
| 5 |
Hao Chen, Huabing Tan, Juan Wan, Yong Zeng, Jincheng Wang, Haichuan Wang, Xiaojie Lu. PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets. Pharmacology & Therapeutics 2023; 245: 108391 doi: 10.1016/j.pharmthera.2023.108391
|
| 6 |
Yu-Gang Wang, Min Shi, Ting Wang, Ting Shi, Jue Wei, Na Wang, Xi-Mei Chen. Signal transduction mechanism of TRB3 in rats with non-alcoholic fatty liver disease. World Journal of Gastroenterology 2009; 15(19): 2329-2335 doi: 10.3748/wjg.15.2329
|
| 7 |
Nora Martínez, Verónica White, Melisa Kurtz, Romina Higa, Evangelina Capobianco, Alicia Jawerbaum. Activation of the nuclear receptor PPARα regulates lipid metabolism in foetal liver from diabetic rats: implications in diabetes‐induced foetal overgrowth. Diabetes/Metabolism Research and Reviews 2011; 27(1): 35 doi: 10.1002/dmrr.1151
|
| 8 |
Jun Wang, Xufeng Guo, Pengbo Wu, Jia Song, Chuncui Ye, Shijie Yu, Jixiang Zhang, Weiguo Dong. Association between the Pro12Ala polymorphism of PPAR-γ gene and the non-alcoholic fatty liver disease: A meta-analysis. Gene 2013; 528(2): 328 doi: 10.1016/j.gene.2013.07.014
|
| 9 |
James E. Nelson, Elizabeth M. Brunt, Kris V. Kowdley. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282YHFEmutations. Hepatology 2012; 56(5): 1730 doi: 10.1002/hep.25856
|
| 10 |
Yan Cui, Xiaoli Wang, Jie Xue, Jiangyun Liu, Meilin Xie. Chrysanthemum morifolium extract attenuates high-fat milk-induced fatty liver through peroxisome proliferator-activated receptor α–mediated mechanism in mice. Nutrition Research 2014; 34(3): 268 doi: 10.1016/j.nutres.2013.12.010
|
| 11 |
Sharanappa T. Talawar, Kiran Gangappa, Sharavana Gurunathan, Mayookha V.P, Suresh Kumar Gurusiddaiah. Sterol Ferulate Rich Wheat Bran Oil Concentrate Prevents Liver Damage in MAFLD Mouse Model by Modulating FAS and PCSK9. ACS Food Science & Technology 2021; 1(4): 644 doi: 10.1021/acsfoodscitech.0c00156
|
| 12 |
Amedeo Lonardo, Simona Leoni, Khalid A. Alswat, Yasser Fouad. History of Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2020; 21(16): 5888 doi: 10.3390/ijms21165888
|
| 13 |
Maryam Ahmadian, Jae Myoung Suh, Nasun Hah, Christopher Liddle, Annette R Atkins, Michael Downes, Ronald M Evans. PPARγ signaling and metabolism: the good, the bad and the future. Nature Medicine 2013; 19(5): 557 doi: 10.1038/nm.3159
|
| 14 |
Ebrahim Abbasi Oshaghi, Arash Noori Sorkhani, Ali Rezaei. Effects of Walnut on Lipid Profile as Well as the Expression of Sterol-Regulatory Element Binding Protein-1c(SREBP-1c) and Peroxisome Proliferator Activated Receptors <i>α</i> (PPAR<i>α</i>) in Diabetic Rat. Food and Nutrition Sciences 2012; 3(02): 255 doi: 10.4236/fns.2012.32037
|
| 15 |
Rohan K. Henry. Growth Hormone Deficiency and Nonalcoholic Fatty Liver Disease with Insights from Humans and Animals: Pediatric Implications. Metabolic Syndrome and Related Disorders 2018; 16(10): 507 doi: 10.1089/met.2018.0056
|
| 16 |
Hemda Schmilovitz-Weiss, Edith Hochhauser, Michal Cohen, Yelena Chepurko, Smadar Yitzhaki, Ehud Grossman, Avshalom Leibowitz, Zvi Ackerman, Ziv Ben-Ari. Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease - A historical prospective. Lipids in Health and Disease 2013; 12(1) doi: 10.1186/1476-511X-12-41
|
| 17 |
Mônica Souza de MIRANDA-HENRIQUES, Margareth de Fátima Formiga de Melo DINIZ, Maria Salete Trigueiro de ARAÚJO. GINSENG, GREEN TEA OR FIBRATE: valid options for nonalcoholic steatohepatitis prevention?. Arquivos de Gastroenterologia 2014; 51(3): 255 doi: 10.1590/S0004-28032014000300016
|
| 18 |
S. Kaser, C. F. Ebenbichler, H. Tilg. Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease. International Journal of Clinical Practice 2010; 64(7): 968 doi: 10.1111/j.1742-1241.2009.02327.x
|
| 19 |
Nur Abu Ahmad, Merav Raizman, Nathalie Weizmann, Brandi Wasek, Erland Arning, Teodoro Bottiglieri, Oren Tirosh, Aron M. Troen. Betaine attenuates pathology by stimulating lipid oxidation in liver and regulating phospholipid metabolism in brain of methionine‐choline–deficient rats. The FASEB Journal 2019; 33(8): 9334 doi: 10.1096/fj.201802683R
|
| 20 |
Nayeon Kim, Sunyoon Jung, Eunjung Lee, Eun-Byeol Jo, Seongjun Yoon, Yoonhwa Jeong. Gryllus bimaculatus De Geer hydrolysates alleviate lipid accumulation, inflammation, and endoplasmic reticulum stress in palmitic acid-treated human hepatoma G2 cells. Journal of Ethnopharmacology 2022; 291: 115117 doi: 10.1016/j.jep.2022.115117
|
| 21 |
Simona D’Amore, Giuseppe Palasciano, Antonio Moschetta. A Systems Biology Approach to Study Metabolic Syndrome. 2014; : 27 doi: 10.1007/978-3-319-01008-3_3
|
| 22 |
Xi Zhao, Feng Wang, Ruijun Zhou, Zengyan Zhu, Meilin Xie. PPARα/γ antagonists reverse the ameliorative effects of osthole on hepatic lipid metabolism and inflammatory response in steatohepatitic rats. Inflammopharmacology 2018; 26(2): 425 doi: 10.1007/s10787-017-0327-2
|
| 23 |
Linhao Li, Haishan Li, Brandy Garzel, Hui Yang, Tatsuya Sueyoshi, Qing Li, Yan Shu, Junran Zhang, Bingfang Hu, Scott Heyward, Timothy Moeller, Wen Xie, Masahiko Negishi, Hongbing Wang. SLC13A5 Is a Novel Transcriptional Target of the Pregnane X Receptor and Sensitizes Drug-Induced Steatosis in Human Liver. Molecular Pharmacology 2015; 87(4): 674 doi: 10.1124/mol.114.097287
|
| 24 |
Sven Francque, An Verrijken, Sandrine Caron, Janne Prawitt, Réjane Paumelle, Bruno Derudas, Philippe Lefebvre, Marja-Riitta Taskinen, Wim Van Hul, Ilse Mertens, Guy Hubens, Eric Van Marck, Peter Michielsen, Luc Van Gaal, Bart Staels. PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis. Journal of Hepatology 2015; 63(1): 164 doi: 10.1016/j.jhep.2015.02.019
|
| 25 |
Chien-Wei Lee, Wei-Ting Hsiao, Oscar Kuang-Sheng Lee. Mesenchymal stromal cell-based therapies reduce obesity and metabolic syndromes induced by a high-fat diet. Translational Research 2017; 182: 61 doi: 10.1016/j.trsl.2016.11.003
|
| 26 |
David Q.‐H. Wang, Piero Portincasa, Brent A. Neuschwander‐Tetri. Comprehensive Physiology. 2013; : 1493 doi: 10.1002/cphy.c130001
|
| 27 |
Smriti Mittal, Shrirang Inamdar, Jhankar Acharya, Komal Pekhale, Saurabh Kalamkar, Ramanamurthy Boppana, Saroj Ghaskadbi. miR-3666 inhibits development of hepatic steatosis by negatively regulating PPARγ. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(10): 158777 doi: 10.1016/j.bbalip.2020.158777
|
| 28 |
Igor P Pogribny, Frederick A Beland. Role of microRNAs in the regulation of drug metabolism and disposition genes in diabetes and liver disease. Expert Opinion on Drug Metabolism & Toxicology 2013; 9(6): 713 doi: 10.1517/17425255.2013.783817
|
| 29 |
Marta Varela-Rey, Nieves Embade, Usue Ariz, Shelly C. Lu, José M. Mato, M. Luz Martínez-Chantar. Non-alcoholic steatohepatitis and animal models: Understanding the human disease. The International Journal of Biochemistry & Cell Biology 2009; 41(5): 969 doi: 10.1016/j.biocel.2008.10.027
|
| 30 |
Miey Park, Anshul Sharma, Chaewon Kang, Jinyoung Han, Kumud Malika Tripathi, Hae-Jeung Lee. N-Doped Carbon Nanorods from Biomass as a Potential Antidiabetic Nanomedicine. ACS Biomaterials Science & Engineering 2022; 8(5): 2131 doi: 10.1021/acsbiomaterials.1c01598
|
| 31 |
Luis A. Videla, Paulina Pettinelli. Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity. PPAR Research 2012; 2012: 1 doi: 10.1155/2012/107434
|
| 32 |
Nora Anderson, Jürgen Borlak. Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis. Pharmacological Reviews 2008; 60(3): 311 doi: 10.1124/pr.108.00001
|
| 33 |
Hee Jae Lee, Soo Jin Yang. Effects of resveratrol on hepatic autophagy in high fat diet-induced obese mice. Journal of Nutrition and Health 2013; 46(4): 307 doi: 10.4163/jnh.2013.46.4.307
|
| 34 |
Birgit Waltenberger, Atanas G. Atanasov, Elke H. Heiss, David Bernhard, Judith M. Rollinger, Johannes M. Breuss, Daniela Schuster, Rudolf Bauer, Brigitte Kopp, Chlodwig Franz, Valery Bochkov, Marko D. Mihovilovic, Verena M. Dirsch, Hermann Stuppner. Drugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network project. Monatshefte für Chemie - Chemical Monthly 2016; 147(3): 479 doi: 10.1007/s00706-015-1653-y
|
| 35 |
Leila Saremi, Shirin Lotfipanah, Masumeh Mohammadi, Hassan Hosseinzadeh, Mina Fathi-Kazerooni, Behrooz Johari, Zohreh Saltanatpour. The Pro12Ala polymorphism in the PPARγ2 gene is not associated with an increased risk of NAFLD in Iranian patients with type 2 diabetes mellitus. Cellular & Molecular Biology Letters 2019; 24(1) doi: 10.1186/s11658-019-0138-0
|
| 36 |
Brent A. Neuschwander-Tetri. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites. Hepatology 2010; 52(2): 774 doi: 10.1002/hep.23719
|
| 37 |
Chuang-Yu Cao, Yu-Yuan Li, Yong-Jian Zhou, Yu-Qiang Nie, Yu-Jui Yvonne Wan. The C-681G Polymorphism of the PPAR-γ Gene Is Associated with Susceptibility to Non-Alcoholic Fatty Liver Disease. The Tohoku Journal of Experimental Medicine 2012; 227(4): 253 doi: 10.1620/tjem.227.253
|
| 38 |
Lina Xu, Yongli Wei, Deshi Dong, Lianhong Yin, Yan Qi, Xu Han, Youwei Xu, Yanyan Zhao, Kexin Liu, Jinyong Peng. iTRAQ-based proteomics for studying the effects of dioscin against nonalcoholic fatty liver disease in rats. RSC Advances 2014; 4(58): 30704 doi: 10.1039/C4RA03948C
|
| 39 |
Eva-Maria Pferschy-Wenzig, Atanas G. Atanasov, Clemens Malainer, Stefan M. Noha, Olaf Kunert, Daniela Schuster, Elke H. Heiss, Nicholas H. Oberlies, Hildebert Wagner, Rudolf Bauer, Verena M. Dirsch. Identification of Isosilybin A from Milk Thistle Seeds as an Agonist of Peroxisome Proliferator-Activated Receptor Gamma. Journal of Natural Products 2014; 77(4): 842 doi: 10.1021/np400943b
|
| 40 |
Ursa Kovac, Damjana Rozman. Encyclopedia of Life Sciences. 2015; : 1 doi: 10.1002/9780470015902.a0025335
|
| 41 |
Jia-Yu Ke, Kara L Kliewer, Essam M Hamad, Rachel M Cole, Kimerly A Powell, Rebecca R Andridge, Shana R Straka, Lisa D Yee, Martha A Belury. The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice. Nutrition & Metabolism 2015; 12(1) doi: 10.1186/1743-7075-12-1
|
| 42 |
Yuyang Chen, Yao Chen, Lei Zhao, Yaxi Chen, Mei Mei, Qing Li, Ailong Huang, Zac Varghese, John F Moorhead, Xiong Z Ruan. Inflammatory stress exacerbates hepatic cholesterol accumulation via disrupting cellular cholesterol export. Journal of Gastroenterology and Hepatology 2012; 27(5): 974 doi: 10.1111/j.1440-1746.2011.06986.x
|
| 43 |
Livia Alvarenga, Maíra S. Ferreira, Julie A. Kemp, Denise Mafra. The Role of Betaine in Patients With Chronic Kidney Disease: a Narrative Review. Current Nutrition Reports 2022; 11(3): 395 doi: 10.1007/s13668-022-00426-z
|
| 44 |
Valerio Nobili, Gianluca Svegliati-Baroni, Anna Alisi, Luca Miele, Luca Valenti, Pietro Vajro. A 360-degree overview of paediatric NAFLD: Recent insights. Journal of Hepatology 2013; 58(6): 1218 doi: 10.1016/j.jhep.2012.12.003
|
| 45 |
Giselle Adriana Abruzzese, María Florencia Heber, María José Ferrer, Silvana Rocío Ferreira, Aimé Florencia Silva, Alicia Beatriz Motta. Effects of in utero androgen excess and metformin treatment on hepatic functions. Molecular and Cellular Endocrinology 2019; 491: 110416 doi: 10.1016/j.mce.2019.03.006
|
| 46 |
Bregje Van De Wier, Ger H. Koek, Aalt Bast, Guido R. M. M. Haenen. The potential of flavonoids in the treatment of non-alcoholic fatty liver disease. Critical Reviews in Food Science and Nutrition 2017; 57(4): 834 doi: 10.1080/10408398.2014.952399
|
| 47 |
Chengdong Xia, Xiuli Zhang, Tianshu Cao, Jiannong Wang, Cuidan Li, Liya Yue, Kaifeng Niu, Yicheng Shen, Guannan Ma, Fei Chen. Hepatic Transcriptome Analysis Revealing the Molecular Pathogenesis of Type 2 Diabetes Mellitus in Zucker Diabetic Fatty Rats. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.565858
|
| 48 |
James E. Nelson, Heather Klintworth, Kris V. Kowdley. Iron Metabolism in Nonalcoholic Fatty Liver Disease. Current Gastroenterology Reports 2012; 14(1): 8 doi: 10.1007/s11894-011-0234-4
|
| 49 |
Kewei Wang, Rong Zhang, Nadja Lehwald, Guo-Zhong Tao, Bowen Liu, Bo Liu, Yangseok Koh, Karl G. Sylvester. Wnt/β-catenin signaling activation promotes lipogenesis in the steatotic liver via physical mTOR interaction. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1289004
|
| 50 |
Sun-Sil Choi, Jiyoung Park, Jang Hyun Choi. Revisiting PPARγ as a target for the treatment of metabolic disorders. BMB Reports 2014; 47(11): 599 doi: 10.5483/BMBRep.2014.47.11.174
|
| 51 |
Fabien Forcheron, Pauline Abdallah, Alexandra Basset, Peggy del Carmine, Ghina Haffar, Michel Beylot. Nonalcoholic Hepatic Steatosis in Zucker Diabetic Rats: Spontaneous Evolution and Effects of Metformin and Fenofibrate. Obesity 2009; 17(7): 1381 doi: 10.1038/oby.2008.661
|
| 52 |
Yu-Gang Wang, Wen-Li Fang, Jue Wei, Ting Wang, Na Wang, Jia-Li Ma, Min Shi. The involvement of NLRX1 and NLRP3 in the development of nonalcoholic steatohepatitis in mice. Journal of the Chinese Medical Association 2013; 76(12): 686 doi: 10.1016/j.jcma.2013.08.010
|
| 53 |
Yi Shang, Takamitsu Morioka, Kazuhiro Daino, Takafumi Nakayama, Mayumi Nishimura, Shizuko Kakinuma. Ionizing radiation promotes, whereas calorie restriction suppresses, NASH and hepatocellular carcinoma in mice. International Journal of Cancer 2023; 153(8): 1529 doi: 10.1002/ijc.34651
|
| 54 |
Hajime Ishii, Yasuo Horie, Shigetoshi Ohshima, Yumiko Anezaki, Nobukatsu Kinoshita, Takahiro Dohmen, Ei Kataoka, Wataru Sato, Takashi Goto, Junko Sasaki, Takehiko Sasaki, Sumio Watanabe, Akira Suzuki, Hirohide Ohnishi. Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice. Journal of Hepatology 2009; 50(3): 562 doi: 10.1016/j.jhep.2008.10.031
|
| 55 |
Fouzia Gul, Nousheen Parvaiz, Syed Sikander Azam, Arabinda Ghosh. Deciphering the relational dynamics of AF-2 domain of PAN PPAR through drug repurposing and comparative simulations. PLOS ONE 2023; 18(3): e0283743 doi: 10.1371/journal.pone.0283743
|
| 56 |
Ko Morishita, Tomohiro Miike, Shigemitsu Takeda, Masaki Fukui, Yuma Ito, Tatsuya Kitao, Shin-ichiro Ozawa, Shuichi Hirono, Hiroaki Shirahase. (<i>S</i>)-1,2,3,4-Tetrahydroisoquinoline Derivatives Substituted with an Acidic Group at the 6-Position as a Selective Peroxisome Proliferator-Activated Receptor γ Partial Agonist. Chemical and Pharmaceutical Bulletin 2019; 67(11): 1211 doi: 10.1248/cpb.c19-00541
|
| 57 |
Timothy P. LaBranche, Anna K. Kopec, Srinivasa R. Mantena, Brett D. Hollingshead, Andrew W. Harrington, Zachary S. Stewart, Yutian Zhan, Kyle D. Hayes, Laurence O. Whiteley, Andrew D. Burdick, John W. Davis. Zucker Lean Rats With Hepatic Steatosis Recapitulate Asymptomatic Metabolic Syndrome and Exhibit Greater Sensitivity to Drug-Induced Liver Injury Compared With Standard Nonclinical Sprague-Dawley Rat Model. Toxicologic Pathology 2020; 48(8): 994 doi: 10.1177/0192623320968716
|
| 58 |
Nicolas Leuenberger, Walter Wahli. Signaling Pathways in Liver Diseases. 2010; : 305 doi: 10.1007/978-3-642-00150-5_20
|
| 59 |
Gene P. Ables. Update on Ppar and Nonalcoholic Fatty Liver Disease. PPAR Research 2012; 2012: 1 doi: 10.1155/2012/912351
|
| 60 |
Xi Zhao, Jie Xue, Meilin Xie. Osthole inhibits oleic acid/lipopolysaccharide-induced lipid accumulation and inflammatory response through activating PPARα signaling pathway in cultured hepatocytes. Experimental Gerontology 2019; 119: 7 doi: 10.1016/j.exger.2019.01.014
|
| 61 |
Anna Iacono, Giuseppina Mattace Raso, Roberto Berni Canani, Antonio Calignano, Rosaria Meli. Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. The Journal of Nutritional Biochemistry 2011; 22(8): 699 doi: 10.1016/j.jnutbio.2010.10.002
|
| 62 |
Salwa A. Ibrahim, Mervat Z. Mohamed, Nashwa F. El-Tahawy, Aly M. Abdelrahman. Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats. Canadian Journal of Physiology and Pharmacology 2021; 99(3): 313 doi: 10.1139/cjpp-2020-0159
|
| 63 |
Lin Ding, Jun-Lin Liu, Waseem Hassan, Lu-Lu Wang, Fang-Rong Yan, Jing Shang. Lipid modulatory activities of Cichorium glandulosum Boiss et Huet are mediated by multiple components within hepatocytes. Scientific Reports 2014; 4(1) doi: 10.1038/srep04715
|
| 64 |
Tereza Ventura-Holman, Abulkhair Mamoon, Maria C. Subauste, Jose S. Subauste. The effect of oncoprotein v-erbA on thyroid hormone-regulated genes in hepatocytes and their potential role in hepatocellular carcinoma. Molecular Biology Reports 2011; 38(2): 1137 doi: 10.1007/s11033-010-0211-2
|
| 65 |
Deepti G. Bulchandani, Jagdish S. Nachnani, Anupama Nookala, Christina Naumovitch, Betty Herndon, Agostino Molteni, Tim Quinn, Laura M. Alba. Treatment with Ω-3 fatty acids but not exendin-4 improves hepatic steatosis. European Journal of Gastroenterology & Hepatology 2010; 22(10): 1245 doi: 10.1097/MEG.0b013e32833b257a
|
| 66 |
Jiashu Pan, Wenjun Zhou, Ruohui Xu, Lianjun Xing, Guang Ji, Yanqi Dang. Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease. Biomedicine & Pharmacotherapy 2022; 151: 113127 doi: 10.1016/j.biopha.2022.113127
|
| 67 |
Pragati Singh, Mohammad Irshad Reza, Anees A. Syed, Athar Husain, Jiaur R. Gayen. Pancreastatin deteriorates hepatic lipid metabolism via elevating fetuin B in ovariectomized rats. Biochimie 2023; 214: 114 doi: 10.1016/j.biochi.2023.06.006
|
| 68 |
Qingming Dong, Michael S. Kuefner, Xiong Deng, Dave Bridges, Edwards A. Park, Marshall B. Elam, Rajendra Raghow. Sex-specific differences in hepatic steatosis in obese spontaneously hypertensive (SHROB) rats. Biology of Sex Differences 2018; 9(1) doi: 10.1186/s13293-018-0202-x
|
| 69 |
Tiangang Li, John Y. L. Chiang. Regulation of Bile Acid and Cholesterol Metabolism by PPARs. PPAR Research 2009; 2009: 1 doi: 10.1155/2009/501739
|
| 70 |
Trinita K. Barboza, Leonardo Susta, Alex zur Linden, Sara Gardhouse, Hugues Beaufrère, Nobuyuki Takahashi. Association of plasma metabolites and diagnostic imaging findings with hepatic lipidosis in bearded dragons (Pogona vitticeps) and effects of gemfibrozil therapy. PLOS ONE 2023; 18(2): e0274060 doi: 10.1371/journal.pone.0274060
|
| 71 |
Michael A. Lomax, Georgios Karamanlidis, John Laws, Stephanie G. Cremers, Peter D. Weinberg, Lynne Clarke. Pigs fed saturated fat/cholesterol have a blunted hypothalamic-pituitary-adrenal function, are insulin resistant and have decreased expression of IRS-1, PGC1α and PPARα. The Journal of Nutritional Biochemistry 2013; 24(4): 656 doi: 10.1016/j.jnutbio.2012.03.013
|
| 72 |
Helga Sauerwein, Susanne Häußler. Endogenous and exogenous factors influencing the concentrations of adiponectin in body fluids and tissues in the bovine. Domestic Animal Endocrinology 2016; 56: S33 doi: 10.1016/j.domaniend.2015.11.007
|
| 73 |
Giuseppina Mattace Raso, Emanuela Esposito, Anna Iacono, Maria Pacilio, Salvatore Cuzzocrea, Roberto Berni Canani, Antonio Calignano, Rosaria Meli. Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat. European Journal of Pharmacology 2009; 604(1-3): 125 doi: 10.1016/j.ejphar.2008.12.013
|
| 74 |
ZHIYAN HUANG, FANG FANG, CHI-WAI WONG. GANODERMA LUCIDUM SPORE LIPID INDUCES PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA ACTIVITY. Journal of Food Biochemistry 2011; 35(5): 1508 doi: 10.1111/j.1745-4514.2010.00472.x
|
| 75 |
Kun Zhu, Yi Tang, Xuan Xu, Hien Dang, Liu-Ya Tang, Xiang Wang, Xin Wei Wang, Ying E. Zhang, Brian Finck. Non-proteolytic ubiquitin modification of PPARγ by Smurf1 protects the liver from steatosis. PLOS Biology 2018; 16(12): e3000091 doi: 10.1371/journal.pbio.3000091
|
| 76 |
Muhammed Seyithanoğlu, Yıldız Öner-İyidoğan, Semra Doğru-Abbasoğlu, Sevda Tanrıkulu-Küçük, Hikmet Koçak, Şule Beyhan-Özdaş, Necla Koçak-Toker. The effect of dietary curcumin and capsaicin on hepatic fetuin-A expression and fat accumulation in rats fed on a high-fat diet. Archives of Physiology and Biochemistry 2016; 122(2): 94 doi: 10.3109/13813455.2015.1120753
|
| 77 |
Adviti Naik, Rok Košir, Damjana Rozman. Genomic aspects of NAFLD pathogenesis. Genomics 2013; 102(2): 84 doi: 10.1016/j.ygeno.2013.03.007
|
| 78 |
Hung-Tsung Wu, Wency Chen, Kai-Chun Cheng, Po-Ming Ku, Ching-Hua Yeh, Juei-Tang Cheng. Oleic acid activates peroxisome proliferator-activated receptor δ to compensate insulin resistance in steatotic cells. The Journal of Nutritional Biochemistry 2012; 23(10): 1264 doi: 10.1016/j.jnutbio.2011.07.006
|
| 79 |
Gaoxin Zhang, Lingling Meng, Jiehong Guo, Xiaoling Guan, Mei Liu, Xu Han, Yingming Li, Qinghua Zhang, Guibin Jiang. Exposure to novel brominated and organophosphate flame retardants and associations with type 2 diabetes in East China: A case-control study. Science of The Total Environment 2023; 871: 162107 doi: 10.1016/j.scitotenv.2023.162107
|
| 80 |
Xiang Zhang, Yarong Hao. <p>Beneficial Effects of Echinacoside on Diabetic Cardiomyopathy in Diabetic <em>Db/Db</em> Mice</p>. Drug Design, Development and Therapy 2020; : 5575 doi: 10.2147/DDDT.S276972
|
| 81 |
Maria Luz Maia, Sara Sousa, Diogo Pestana, Ana Faria, Diana Teixeira, Cristina Delerue-Matos, Valentina Fernandes Domingues, Conceição Calhau. Impact of brominated flame retardants on lipid metabolism: An in vitro approach. Environmental Pollution 2022; 294: 118639 doi: 10.1016/j.envpol.2021.118639
|
| 82 |
Kira Bettermann, Tabea Hohensee, Johannes Haybaeck. Steatosis and Steatohepatitis: Complex Disorders. International Journal of Molecular Sciences 2014; 15(6): 9924 doi: 10.3390/ijms15069924
|
| 83 |
Wen-Dee Chiang, Marthandam Asokan Shibu, Kuei-I Lee, Jia-Ping Wu, Fuu-Jen Tsai, Lung-Fa Pan, Chih-Yang Huang, Wan-Teng Lin. Lipolysis-stimulating peptide-VHVV ameliorates high fat diet induced hepatocyte apoptosis and fibrosis. Journal of Functional Foods 2014; 11: 482 doi: 10.1016/j.jff.2014.08.003
|
| 84 |
Yu Yuan Li, Dan Tang, Yan Lei Du, Chuang Yu Cao, Yu Qiang Nie, Jie Cao, Yong Jian Zhou. Fatty liver mediated by peroxisome proliferator‐activated receptor‐α DNA methylation can be reversed by a methylation inhibitor and curcumin. Journal of Digestive Diseases 2018; 19(7): 421 doi: 10.1111/1751-2980.12610
|
| 85 |
Pavani K. Gonnabathula, Momoh Audu Yakubu. Emerging contaminants at trace levels of pesticides perturbs biomolecules in different organs in mice: Role of peroxisome proliferator-activated receptor-alpha. American Journal of Biopharmacy and Pharmaceutical Sciences 2024; 4: 1 doi: 10.25259/AJBPS_17_2023
|
| 86 |
Vlad Ratziu. Pharmacological agents for NASH. Nature Reviews Gastroenterology & Hepatology 2013; 10(11): 676 doi: 10.1038/nrgastro.2013.193
|
| 87 |
Amirhossein Sahebkar. Citrus auraptene: A potential multifunctional therapeutic agent for nonalcoholic fatty liver disease. Annals of Hepatology 2011; 10(4): 575 doi: 10.1016/S1665-2681(19)31530-3
|
| 88 |
Mi Hae Seo, Jinmi Lee, Seok-Woo Hong, Eun-Jung Rhee, Se Eun Park, Cheol Young Park, Ki Won Oh, Sung Woo Park, Won-Young Lee, Catherine Mounier. Exendin-4 Inhibits Hepatic Lipogenesis by Increasing β-Catenin Signaling. PLOS ONE 2016; 11(12): e0166913 doi: 10.1371/journal.pone.0166913
|
| 89 |
Omnia Hendawy, Hesham A.M. Gomaa, Shaimaa Hussein, Sami I. Alzarea, Sumera Qasim, Fatema El-Zahraa S. Abdel Rahman, Asmaa T. Ali, Shaimaa R. Ahmed. Cold-pressed raspberry seeds oil ameliorates high-fat diet triggered non-alcoholic fatty liver disease. Saudi Pharmaceutical Journal 2021; 29(11): 1303 doi: 10.1016/j.jsps.2021.09.014
|
| 90 |
Nathan M. Bass. Lipidomic dissection of nonalcoholic steatohepatitis: Moving beyond foie gras to fat traffic. Hepatology 2010; 51(1): 4 doi: 10.1002/hep.23458
|
| 91 |
K. H. Williams, N. A. Shackel, M. D. Gorrell, S. V. McLennan, S. M. Twigg. Diabetes and Nonalcoholic Fatty Liver Disease: A Pathogenic Duo. Endocrine Reviews 2013; 34(1): 84 doi: 10.1210/er.2012-1009
|
| 92 |
Amanda Karolina Soares e Silva, Dilênia de Oliveira Cipriano Torres, Fabiana Oliveira dos Santos Gomes, Bruna dos Santos Silva, Edlene Lima Ribeiro, Amanda Costa Oliveira, Laise Aline Martins dos Santos, Maria do Carmo Alves de Lima, Ivan da Rocha Pitta, Christina Alves Peixoto, Patricia Aspichueta. LPSF/GQ-02 Inhibits the Development of Hepatic Steatosis and Inflammation in a Mouse Model of Non-Alcoholic Fatty Liver Disease (NAFLD). PLOS ONE 2015; 10(4): e0123787 doi: 10.1371/journal.pone.0123787
|
| 93 |
Su-Xing Wang, Jin-Gang Wei, Lu-Lu Chen, Xiang Hu, Wen Kong. The role of expression imbalance between adipose synthesis and storage mediated by PPAR-γ/FSP27 in the formation of insulin resistance in catch up growth. Lipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0319-z
|
| 94 |
Kamran Qureshi, Brent A. Neuschwander-Tetri. The molecular basis for current targets of NASH therapies. Expert Opinion on Investigational Drugs 2020; 29(2): 151 doi: 10.1080/13543784.2020.1703949
|
| 95 |
Noel C. Salvoza, Pablo J. Giraudi, Claudio Tiribelli, Natalia Rosso. Sex differences in non-alcoholic fatty liver disease: hints for future management of the disease. Exploration of Medicine 2020; 1(2): 51 doi: 10.37349/emed.2020.00005
|
| 96 |
Aimé Florencia Silva, Giselle Adriana Abruzzese, María José Ferrer, María Florencia Heber, Silvana Rocío Ferreira, Gloria Edith Cerrone, Alicia Beatriz Motta. Fetal programming by androgen excess impairs liver lipid content and PPARg expression in adult rats. Journal of Developmental Origins of Health and Disease 2022; 13(3): 300 doi: 10.1017/S2040174421000416
|
| 97 |
Vlad Ratziu, Zachary Goodman, Arun Sanyal. Current efforts and trends in the treatment of NASH. Journal of Hepatology 2015; 62(1): S65 doi: 10.1016/j.jhep.2015.02.041
|
| 98 |
Marta Moya, M. José Gómez-Lechón, José V. Castell, Ramiro Jover. Enhanced steatosis by nuclear receptor ligands: A study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile. Chemico-Biological Interactions 2010; 184(3): 376 doi: 10.1016/j.cbi.2010.01.008
|
| 99 |
Sohair M. M. Ragab, Sary Kh. Abd Elghaffar, Tarek H. El-Metwally, Gamal Badr, Mohamed H. Mahmoud, Hossam M. Omar. Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds. Lipids in Health and Disease 2015; 14(1) doi: 10.1186/s12944-015-0087-1
|
| 100 |
Jessica Jessica, I Made Winarsa Ruma, I Gusti Ayu Widianti. Burdock Root (Arctium lappa) Reduces Steatosis and Serum Malondialdehyde in Wistar Rats Fed with Used Cooking Oil. European Journal of Biomedical Research 2023; 2(3): 1 doi: 10.24018/ejbiomed.2023.2.3.67
|
| 101 |
Jin-Bo Wang, Li-Li Qi, Shui-Di Zheng, Heng-Zheng Wang, Tian-Xing Wu. Curcumin suppresses PPARδ expression and related genes in HT-29 cells. World Journal of Gastroenterology 2009; 15(11): 1346-1352 doi: 10.3748/wjg.15.1346
|
| 102 |
Wen-Ying Chen, Chun-Jung Chen, Chia-Hsin Liu, Frank Chiahung Mao. Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ mice. Biochemical and Biophysical Research Communications 2010; 397(3): 459 doi: 10.1016/j.bbrc.2010.05.129
|
| 103 |
Ki Kwang Oh, Md. Adnan, Dong Ha Cho. Network pharmacology approach to bioactive chemical compounds identified from Lespedeza bicolor lignum methanol extract by GC–MS for amelioration of hepatitis. Gene Reports 2020; 21: 100851 doi: 10.1016/j.genrep.2020.100851
|
| 104 |
Shaoyun Wang, Amrita Kamat, Pablo Pergola, Anita Swamy, Fermin Tio, Kenneth Cusi. Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo. Metabolism 2011; 60(8): 1090 doi: 10.1016/j.metabol.2010.12.001
|
| 105 |
Ting Wang, Yasuhiro Takikawa, Takahito Tabuchi, Takumi Satoh, Kunio Kosaka, Kazuyuki Suzuki. Carnosic acid (CA) prevents lipid accumulation in hepatocytes through the EGFR/MAPK pathway. Journal of Gastroenterology 2012; 47(7): 805 doi: 10.1007/s00535-012-0546-7
|
| 106 |
Amalia Gastaldelli, Stephen A. Harrison, Renata Belfort-Aguilar, Lou Jean Hardies, Bogdan Balas, Steven Schenker, Kenneth Cusi. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology 2009; 50(4): 1087 doi: 10.1002/hep.23116
|
| 107 |
Amirhossein Sahebkar. Does PPARγ2 Gene Pro12Ala Polymorphism Affect Nonalcoholic Fatty Liver Disease Risk? Evidence from a Meta-Analysis. DNA and Cell Biology 2013; 32(4): 188 doi: 10.1089/dna.2012.1947
|
| 108 |
G. Ramadori, Pierluigi Ramadori. Signaling Pathways in Liver Diseases. 2010; : 3 doi: 10.1007/978-3-642-00150-5_1
|
| 109 |
Jing Zhong, Xiaofang He, Xinxin Gao, Qiaohong Liu, Yu Zhao, Ying Hong, Weize Zhu, Juan Yan, Yifan Li, Yan Li, Ningning Zheng, Yiyang Bao, Hao Wang, Junli Ma, Wenjin Huang, Zekun Liu, Yuanzhi Lyu, Xisong Ke, Wei Jia, Cen Xie, Yiyang Hu, Lili Sheng, Houkai Li. Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-41061-8
|
| 110 |
Xavier Loyer, Valérie Paradis, Carole Hénique, Anne-Clémence Vion, Nathalie Colnot, Coralie L Guerin, Cécile Devue, Sissi On, Jérémy Scetbun, Mélissa Romain, Jean-Louis Paul, Marc E Rothenberg, Patrick Marcellin, François Durand, Pierre Bedossa, Carina Prip-Buus, Eric Baugé, Bart Staels, Chantal M Boulanger, Alain Tedgui, Pierre-Emmanuel Rautou. Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression. Gut 2016; 65(11): 1882 doi: 10.1136/gutjnl-2014-308883
|
| 111 |
Yi Yin, Zhiwen Yu, Min Xia, Xiaoqin Luo, Xiaofei Lu, Wenhua Ling. Vitamin D attenuates high fat diet–induced hepatic steatosis in rats by modulating lipid metabolism. European Journal of Clinical Investigation 2012; 42(11): 1189 doi: 10.1111/j.1365-2362.2012.02706.x
|
| 112 |
Senling Feng, Jing Zhang, Baoying Liang, Hongliu Jin, Zhongwen Yuan. Effects of cyclocarya paliurus flavonoid extract in non-alcoholic steatohepatitis mice: Intermeshing network pharmacology and in vivo pharmacological evaluation. Pharmacognosy Magazine 2021; 17(76): 765 doi: 10.4103/pm.pm_21_21
|
| 113 |
Marion Peyrou, Pierluigi Ramadori, Lucie Bourgoin, Michelangelo Foti. PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs. PPAR Research 2012; 2012: 1 doi: 10.1155/2012/757803
|
| 114 |
Haifeng Zhang, Yuxiu He, Pak Kwong Chung, Tom K. Tong, Frank H. Fu, Yujuan Chen, Guangfa Jiao. Effects of 12 Weeks of Exercise on Hepatic TNF-α and PPARα in an Animal Model of High-Fat Diet-Induced Nonalcoholic Steatohepatitis. Journal of Exercise Science & Fitness 2009; 7(1): 18 doi: 10.1016/S1728-869X(09)60003-4
|
| 115 |
Namthip Witayavanitkul, Duangporn Werawatganon, Maneerat Chayanupatkul, Naruemon Klaikeaw, Sompol Sanguanrungsirikul, Prasong Siriviriyakul. Genistein and exercise modulated lipid peroxidation and improved steatohepatitis in ovariectomized rats. BMC Complementary Medicine and Therapies 2020; 20(1) doi: 10.1186/s12906-020-02962-z
|
| 116 |
Yali Zhang, Beibei Wu, Hailing Zhang, Xiangting Ge, Shilong Ying, Mengwei Hu, Weixin Li, Yi Huang, Li Wang, Chao Chen, Xiaoou Shan, Guang Liang. Inhibition of MD2‐dependent inflammation attenuates the progression of non‐alcoholic fatty liver disease. Journal of Cellular and Molecular Medicine 2018; 22(2): 936 doi: 10.1111/jcmm.13395
|
| 117 |
Tongxi Zhou, Guanjun Song, Di Tian, Qinghua Liu, Jinhua Shen, Xinzhou Yang, Ping Zhao. Nuciferine relieves type 2 diabetes mellitus via enhancing GLUT4 expression and translocation. Food Science and Human Wellness 2023; 12(6): 2040 doi: 10.1016/j.fshw.2023.03.020
|
| 118 |
Rhema Khairnar, Md Asrarul Islam, Joshua Fleishman, Sunil Kumar. Shedding light on non-alcoholic fatty liver disease: Pathogenesis, molecular mechanisms, models, and emerging therapeutics. Life Sciences 2023; 312: 121185 doi: 10.1016/j.lfs.2022.121185
|
| 119 |
Amirhossein Sahebkar, Gerard T Chew, Gerald F Watts. New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease. Expert Opinion on Pharmacotherapy 2014; 15(4): 493 doi: 10.1517/14656566.2014.876992
|